Rx only · Injection, Solution · Intravenous
Moxifloxacin Hydrochloride
Moxifloxacin Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATCJ01MA14
RxCUI (US)139462
US makers3 labelers
Packages3
DEA / ScheduleNone
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
110
Rx · 2026 Q1
8.8K
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Institutional LLC | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Hp Halden Pharma AS | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 29, 2025RESOLVEDShortage resolved: Moxifloxacin Injection (Fresenius Kabi USA, LLC)
Moxifloxacin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anti-Infective.
- Oct 29, 2025SHORTAGEDrug shortage: Moxifloxacin Injection (Fresenius Kabi USA, LLC)
Moxifloxacin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anti-Infective.
Pill